Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ACE2 and pACE2: A Pair of Aces for Pulmonary Arterial Hypertension Treatment?

Literature DB >> 29634285

ACE2 and pACE2: A Pair of Aces for Pulmonary Arterial Hypertension Treatment?

Elaine M Richards¹, Mohan K Raizada¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2018 PMID： 29634285 PMCID： PMC6118027 DOI： 10.1164/rccm.201803-0569ED

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

× No keyword cloud information.

14 in total

1. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.

Authors: Gang Li; Han Zhang; Lei Zhao; Yaozhong Zhang; Daole Yan; Yinglong Liu
Journal: J Am Soc Hypertens Date: 2017-10-28

2. AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension.

Authors: Jiao Zhang; Jianjie Dong; Marcy Martin; Ming He; Brendan Gongol; Traci L Marin; Lili Chen; Xinxing Shi; Yanjun Yin; Fenqing Shang; Yan Wu; Hsi-Yuan Huang; Jin Zhang; Yu Zhang; Jian Kang; Esteban A Moya; Hsien-Da Huang; Frank L Powell; Zhen Chen; Patricia A Thistlethwaite; Zu-Yi Yuan; John Y-J Shyy
Journal: Am J Respir Crit Care Med Date: 2018-08-15 Impact factor: 21.405

Review 3. Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease.

Authors: Hongpeng Jia
Journal: Shock Date: 2016-09 Impact factor: 3.454

4. Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg⁹ bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration.

Authors: Chhinder P Sodhi; Christine Wohlford-Lenane; Yukihiro Yamaguchi; Thomas Prindle; William B Fulton; Sanxia Wang; Paul B McCray; Mark Chappell; David J Hackam; Hongpeng Jia
Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-09-21 Impact factor: 5.464

Review 5. ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Authors: Colleen T Cole-Jeffrey; Meng Liu; Michael J Katovich; Mohan K Raizada; Vinayak Shenoy
Journal: J Cardiovasc Pharmacol Date: 2015-12 Impact factor: 3.105

6. Estradiol, acting through ERα, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1-7 production.

Authors: Ana Mompeón; Macarena Lázaro-Franco; Carlos Bueno-Betí; Daniel Pérez-Cremades; Xavier Vidal-Gómez; Elena Monsalve; Mariela M Gironacci; Carlos Hermenegildo; Susana Novella
Journal: Mol Cell Endocrinol Date: 2015-11-11 Impact factor: 4.102

7. Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA.

Authors: Eva Schrom; Maja Huber; Manish Aneja; Christian Dohmen; Daniela Emrich; Johannes Geiger; Günther Hasenpusch; Annika Herrmann-Janson; Verena Kretzschmann; Olga Mykhailyk; Tamara Pasewald; Prajakta Oak; Anne Hilgendorff; Dirk Wohlleber; Heinz-Gerd Hoymann; Dirk Schaudien; Christian Plank; Carsten Rudolph; Rebekka Kubisch-Dohmen
Journal: Mol Ther Nucleic Acids Date: 2017-04-13

Review 8. The Gut, Its Microbiome, and Hypertension.

Authors: Elaine M Richards; Carl J Pepine; Mohan K Raizada; Seungbum Kim
Journal: Curr Hypertens Rep Date: 2017-04 Impact factor: 5.369

9. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

Authors: Daniel W Lambert; Mike Yarski; Fiona J Warner; Paul Thornhill; Edward T Parkin; A Ian Smith; Nigel M Hooper; Anthony J Turner
Journal: J Biol Chem Date: 2005-06-27 Impact factor: 5.157

10. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors: Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal: Nature Date: 2003-11-27 Impact factor: 49.962

8 in total

Review 1. Pulmonary hypertension: Pathophysiology beyond the lung.

Authors: Aline C Oliveira; Elaine M Richards; Mohan K Raizada
Journal: Pharmacol Res Date: 2019-11-13 Impact factor: 7.658

2. Theoretical Investigation of the Coronavirus SARS-CoV-2 (COVID-19) Infection Mechanism and Selectivity.

Authors: Iga Biskupek; Adam Sieradzan; Cezary Czaplewski; Adam Liwo; Adam Lesner; Artur Giełdoń
Journal: Molecules Date: 2022-03-24 Impact factor: 4.411

Review 3. New understanding of the damage of SARS-CoV-2 infection outside the respiratory system.

Authors: Yuhao Zhang; Xiuchao Geng; Yanli Tan; Qiang Li; Can Xu; Jianglong Xu; Liangchao Hao; Zhaomu Zeng; Xianpu Luo; Fulin Liu; Hong Wang
Journal: Biomed Pharmacother Date: 2020-04-28 Impact factor: 7.419

4. Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's disease.

Authors: Alka A Potdar; Shishir Dube; Takeo Naito; Gregory Botwin; Talin Haritunians; Dalin Li; Shaohong Yang; Janine Bilsborough; Lee A Denson; Mark Daly; Stephan R Targan; Phillip Fleshner; Jonathan Braun; Subra Kugathasan; Thaddeus S Stappenbeck; Dermot P B McGovern
Journal: medRxiv Date: 2020-04-23